Cardiovascular Disease in Lewiston, ME
17 verified cardiovascular disease doctors in Lewiston.
Cardiologists diagnose and treat conditions of the heart and blood vessels, including heart disease, arrhythmias, and heart failure.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Maine Board of Licensure in Medicine
Dr. Patrick Lawrence, MD
Cardiovascular Disease
CMS Open Payments· $19.19 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$19.19
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 36th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Patrick Lawrence do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Daniel Soroff, MD
Cardiovascular Disease
CMS Open Payments· $17.19 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$17.19
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 36th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Daniel Soroff do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Michael Berlowitz, MD
Cardiovascular Disease
CMS Open Payments· $19.18 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$19.18
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 36th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Michael Berlowitz do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Lynette Weeman, DO
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Alan Langburd, MD
Cardiovascular Disease
CMS Open Payments· $67.00 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$67.00
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 43th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Alan Langburd do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Roy Ulin, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Ataollah Letafati, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Mark Kolasa, MD
Cardiovascular Disease
CMS Open Payments· $2,885 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,885
Total received
35
Transactions
9
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 85th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Mark Kolasa do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Lawrence Baker, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Patrick Hohl, DO
Cardiovascular Disease
CMS Open Payments· $20.99 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$20.99
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 37th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Patrick Hohl do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Beata Bajgierowicz, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Steven Hobson, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Dafina Pruthi, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Laura Onderko, MD
Cardiovascular Disease
CMS Open Payments· $15.14 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$15.14
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 35th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Laura Onderko do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jessica Kvasic, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Gemini Yesodharan, MD
Cardiovascular Disease
CMS Open Payments· $2,968 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,968
Total received
32
Transactions
2
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 85th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Gemini Yesodharan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Andrew Geissler, DO
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.